Posted 26 August 2025
Eli Lilly has announced a
significant Mounjaro
price increase
that will affect UK patients starting September 1st, 2025. The pharmaceutical
giant, which manufactures Mounjaro (tirzepatide), has implemented this
pricing change as part of a broader strategy to align UK costs with other
European markets.
| Mounjaro (mg) |
Current Price |
New Price |
% Increase |
| 2.5 mg |
£150 |
£170 |
13.3% |
| 5 mg |
£150 |
£205 |
36.7% |
| 7.5 mg |
£170 |
£260 |
52.9% |
| 10 mg |
£190 |
£290 |
52.6% |
| 12.5 mg |
£215 |
£310 |
44.2% |
| 15 mg |
£215 |
£330 |
53.5% |
Understanding the Mounjaro Price Increase Impact
Why Is Mounjaro Getting More Expensive?
The price increase stems from Eli Lilly's decision to standardize Mounjaro pricing across European markets. This manufacturer-level decision means that all pharmacies including WebMed Pharmacy have no control over the cost adjustments, despite our commitment to maintaining affordable patient care.
What This Means for Current Mounjaro Users
Patients currently benefiting from Mounjaro treatment face uncertainty about continued access to this life-changing medication. We recognize that this price increase affects real people who have experienced remarkable health transformations through Mounjaro (tirzepatide) therapy.
The Life-Changing Impact of Mounjaro Treatment
We have seen extraordinary patient transformations over the past year, including:
-
Significant health improvements
- Restored confidence levels
- Renewed hope for better quality of life
- Sustainable weight management results
These outcomes represent more than clinical statistics—they reflect genuine human experiences and life-changing journeys that the Mounjaro price increase now threatens to disrupt.
AAH, our wholesaler and sole supplier of Mounjaro, is increasing the prices to us from next Thursday 28th August and so we will try not to apply the increase until Monday 1st September. However, this may not be possible as AAH have set monthly quotas and we may not be able to order some strengths that we have run out of until the start of September!
Support Resources During the Price Transition
WebMed Pharmacy Commitment
Despite the challenging price increase, we remain dedicated to:
-
Maintaining transparent communication with patients
- Providing comprehensive guidance throughout the transition
- Ensuring fair treatment access whenever possible
- Offering ongoing support for treatment continuity
Patient Support Options
Patients concerned about the Mounjaro cost changes should know they have access to:
-
Professional healthcare guidance
- Treatment alternative discussions
- Continuous care coordination
Preparing for September 2025 Changes
Taking Action Before the Price Increase
Patients currently using Mounjaro should:
-
Consult with WebMed Pharmacy about treatment options
- Discuss alternative treatment strategies if needed
- Plan for potential cost adjustments in their healthcare budget
Long-term Treatment Planning
The Mounjaro price increase requires patients and providers to develop sustainable long-term treatment strategies that balance clinical effectiveness with financial accessibility.
Moving Forward Despite Pricing Challenges
While the Mounjaro price increase presents significant challenges for UK patients, we remain committed to supporting patient health journeys. The focus continues on ensuring that life-changing treatments remain accessible despite manufacturer pricing decisions beyond local control.
Patients facing concerns about the upcoming price increase should remember that WebMed Pharmacy will offer comprehensive support to help navigate these changes while maintaining their health and wellness goals.
Posted in Weight Loss